Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.66 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Trading Radar For August 12: Hindalco, Adani Enterprises, Bata, Pfizer, Ashoka Buildcon, And Inox Green Are On Stocks Watchlist
Via Stocktwits
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Investing is about looking ahead. 
Via The Motley Fool
Topics Intellectual Property
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
It was a rare breath of fresh air for shareholders. 
Via The Motley Fool
Topics Intellectual Property
Stay informed about the most active stocks in the S&P500 index on Monday's session.
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today
The short-term picture has been less rosy than the longer-term one. 
Via The Motley Fool
Wall Street Has Mixed Opinions On Future Of Arvinas’ Investigational Drug: Retail’s Got A Cautious Approach
Via Stocktwits
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern on board to fill in gaps. 
Via Benzinga
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage. 
Via Benzinga
3 Large-Cap Stocks with Promising Prospects
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
2 Stocks to Buy With $5,000 and Hold for a Decade
These two stocks come from completely different industries, but each could boost a long-term investor's returns. 
Via The Motley Fool
2 Beaten-Down Stocks to Buy and Hold
The market has been tough on these stocks, but a closer look at each is warranted. 
Via The Motley Fool
Topics Intellectual Property
Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
This stock recently bounced on strong Q2 earnings, and the fun could be just getting started. 
Via The Motley Fool
Topics Government World Trade
Positive Gems Becomes the World’s Most Followed Modern Pharmaceutical Brand
Via Get News
Topics Intellectual Property
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
From Arvinas Inc.
Via GlobeNewswire
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Viatris (NASDAQ:VTRS) Beats Q2 Sales Targets, Stock Soars
Medication company Viatris (NASDAQ:VTRS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 5.6% year on year to $3.58 billion. The company expects the full year’s... 
Via StockStory
Political Tremors Rattle Markets: The Profound Impact of U.S. Elections and Tariff Shocks
The intricate dance between political shifts and financial markets has once again taken center stage, demonstrating the profound influence of electoral outcomes and subsequent policy decisions on... 
Via MarketMinute
Topics Economy Government Stocks
Upcoming Earnings Calls This Week: August 4th - August 10th, 2025
This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial... 
Via MarketMinute
Topics Artificial Intelligence Economy
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a significant downturn, plummeting over 10% in premarket trading and continuing to slide throughout the... 
Via MarketMinute
Topics Economy
OPKO Health (OPK) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?
Meeting its dividend commitment this year should be a breeze, but the path ahead is much harder to predict. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
Is It Time to Buy Biotech Stocks?
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech? 
Via The Motley Fool
Wednesday's session: most active stock in the S&P500 index
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
Trump Tweets Trigger Stock Swings For Tesla, Boeing, Pfizer—And An Insider Trading Inquiry
Trump tweets trigger major stock swings for companies like Tesla, Boeing, Pfizer. Democrats demand an investigation. 
Via Benzinga
Topics Government
1 Reason to Buy Pfizer (PFE) Stock
How does $740 in annual income sound? 
Via The Motley Fool
Topics Intellectual Property
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies'
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million. 
Via Benzinga
Stock Market Today: US Futures Edge Higher As Investors Await Earnings From McDonald's, Uber And Walt Disney
US stock futures rose on Wed. after falling on Thurs. Trump threatened tariffs on imported pharma up to 250%. Bond yields down & Fed may cut rates. 
Via Benzinga
Topics Economy Government World Trade
Novo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance. 
Via Stocktwits
Topics Government World Trade
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country'
President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far. 
Via Benzinga
Topics Government World Trade
Nasdaq Dips Over 100 Points Following Economic Data: Investor Sentiment Declines, Fear & Greed Index Moves To 'Neutral' Zone
 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.